Prosight Management, LP Prothena Corp Public LTD CO Transaction History

Prosight Management, LP

  • $369 Million
  • Q2 2025

A detailed history of Prosight Management, LP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Prosight Management, LP holds 267,800 shares of PRTA stock, worth $2.02 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
267,800
Previous 408,122 34.38%
Holding current value
$2.02 Million
Previous $5.05 Million 67.83%
% of portfolio
0.44%
Previous 1.8%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$4.58 - $12.14 $642,674 - $1.7 Million
-140,322 Reduced 34.38%
267,800 $1.63 Million
Q1 2025

May 15, 2025
SELL
$12.38 - $16.04 $123,800 - $160,400
-10,000 Reduced 2.39%
408,122 $5.05 Million
Q4 2024

Feb 14, 2025
SELL
$11.95 - $18.35 $780,872 - $1.2 Million
-65,345 Reduced 13.52%
418,122 $5.79 Million
Q3 2024

Nov 14, 2024
BUY
$16.73 - $24.79 $3.29 Million - $4.87 Million
196,541 Added 68.5%
483,467 $8.09 Million
Q2 2024

Aug 14, 2024
BUY
$19.54 - $26.15 $2.28 Million - $3.05 Million
116,457 Added 68.32%
286,926 $5.92 Million
Q1 2024

May 15, 2024
SELL
$24.75 - $40.66 $1.46 Million - $2.4 Million
-59,070 Reduced 25.73%
170,469 $4.22 Million
Q4 2023

Feb 14, 2024
BUY
$32.31 - $52.32 $3.34 Million - $5.41 Million
103,337 Added 81.88%
229,539 $8.34 Million
Q3 2023

Nov 14, 2023
BUY
$47.3 - $70.6 $293,354 - $437,861
6,202 Added 5.17%
126,202 $6.09 Million
Q2 2023

Aug 14, 2023
SELL
$48.26 - $78.59 $15.8 Million - $25.7 Million
-327,092 Reduced 73.16%
120,000 $8.19 Million
Q1 2023

May 12, 2023
BUY
$46.97 - $58.27 $5.5 Million - $6.82 Million
117,092 Added 35.48%
447,092 $21.7 Million
Q4 2022

Feb 14, 2023
BUY
$52.05 - $65.0 $463,609 - $578,955
8,907 Added 2.77%
330,000 $19.9 Million
Q3 2022

Nov 14, 2022
SELL
$25.16 - $60.63 $5.76 Million - $13.9 Million
-228,907 Reduced 41.62%
321,093 $19.5 Million
Q2 2022

Aug 12, 2022
SELL
$22.73 - $39.98 $375,908 - $661,189
-16,538 Reduced 2.92%
550,000 $14.9 Million
Q1 2022

May 16, 2022
BUY
$30.27 - $49.22 $3.8 Million - $6.18 Million
125,538 Added 28.47%
566,538 $20.7 Million
Q4 2021

Feb 14, 2022
BUY
$42.11 - $73.26 $4.96 Million - $8.62 Million
117,700 Added 36.41%
441,000 $21.8 Million
Q3 2021

Nov 12, 2021
SELL
$48.2 - $78.89 $4.76 Million - $7.79 Million
-98,700 Reduced 23.39%
323,300 $23 Million
Q2 2021

Aug 13, 2021
SELL
$21.63 - $57.65 $3.85 Million - $10.3 Million
-178,000 Reduced 29.67%
422,000 $21.7 Million
Q1 2021

May 14, 2021
SELL
$11.0 - $28.24 $5.4 Million - $13.9 Million
-491,202 Reduced 45.01%
600,000 $15.1 Million
Q4 2020

Feb 12, 2021
BUY
$10.12 - $13.94 $5.53 Million - $7.61 Million
546,007 Added 100.15%
1,091,202 $13.1 Million
Q3 2020

Nov 13, 2020
BUY
$9.93 - $13.47 $5.41 Million - $7.34 Million
545,195 New
545,195 $5.45 Million

Others Institutions Holding PRTA

# of Institutions
219
Shares Held
34.1M
Call Options Held
890K
Put Options Held
791K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $354M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email